Puma Biotechnology, Inc. (PBYI)


NYSE - NYSE Real Time Price. Currency in USD
66.06-1.20 (-1.78%)
At close: 4:01 PM EDT

66.06 0.00 (0.00%)
After hours: 5:53 PM EDT

People also watch:
CLVSICPTKITEMDVNAGIO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open67.08
Prev Close67.26
Bid65.92 x 300
Ask65.99 x 300
Day's Range65.89 - 68.80
52wk Range19.74 - 94.93
1y Target EstN/A
Market Cap2.15B
P/E Ratio (ttm)-8.25
Beta-0.01
Volume964,926
Avg Vol (3m)834,279
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters4 hours ago

    SEC charges former Puma Biotech employee with insider trading

    A former executive for biopharmaceutical company Puma Biotechnology Inc was charged on Thursday by the top U.S. securities regulator and prosecutors with trading on inside information ahead of a company announcement about its breast cancer drug. Robert Gadimian, former regulatory affairs director for Los Angeles-based Puma, pocketed more than $1.1 million by secretly trading on Puma stock based on non-public information he learned about positive developments in two clinical trials for the company's drug, Neratinib, the SEC said in a statement. A U.S. grand jury in Boston on Thursday also indicted Gadimian on felony charges of insider trading, according to court documents.

  • Forbes2 days ago

    Momentum Carries Lululemon Lower, Pushes Biotech Names Higher

    Two biotechs and a technology company are among the three momentum charts to watch today, with the lone short being a retailer. Array BioPharma (ARRY) had an explosive move on Monday, up $2.96, or 81%, to $6.61, on 101 million shares. The company said its melanoma treatments met its primary goal

  • 24/7 Wall St.4 days ago

    6 Biotech and Biohealth Analyst Picks for 50% to 150% Upside

    The week of September 23 brought numerous analyst upgrades and downgrades in the biotech and biohealth space.